A Phase II Trial to Evaluate Single Dose Stereotactic Radiation Therapy (SBRT) Prior to Surgery for Early Stage Breast Carcinoma
Radiation therapy after surgery to remove breast cancer improves control of the breast
cancer. Standard therapy after breast conservation surgery is five to six weeks of radiation
to the entire breast.
This clinical trial will evaluate the effectiveness of conformal radiation therapy delivered
only to the area in the breast where the lumpectomy will be performed.
This study will determine if radiation therapy delivered in this manner will prevent the
cancer from coming back and eliminate the need for five to six weeks of radiation.
The study will also gather information about the safety and effects (good and bad) this
radiation has, and on patient satisfaction with the appearance of the breast.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society